NOVATO, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq:RPTP), today announced that Patrick Reichenberger, VP, Commercial Operations of Raptor will present an overview of the Company at the 2011 BioCentury NewsMakers in the Biotech Industry Conference. Raptor's presentation will take place at the Millennium Broadway Hotel in New York City on Friday, October 21st at 11:30am ET.
A live audio webcast and 14-day archive of the presentation may be accessed via the Investors and Media section of Raptor's website www.raptorpharma.com.
The Raptor Pharmaceutical Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7180
About Raptor Pharmaceutical Corp.
Raptor Pharmaceutical Corp. (Nasdaq:RPTP) ("Raptor") seeks to research, produce, and deliver medicines that improve life for patients with severe, rare disorders. Raptor currently has product candidates in clinical development designed to potentially treat nephropathic cystinosis, Non-alcoholic Steatohepatitis ("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase deficiency ("ALDH2"), and thrombotic disorder.
Raptor's preclinical programs are based upon bioengineered novel drug candidates and drug-targeting platforms derived from the human receptor-associated protein and related proteins that are designed to target cancer, and infectious diseases.
For additional information, please visit www.raptorpharma.com.